Immunitybio Inc(IBRX)— 技术面状态
数据截至2026-10-12 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记,不构成投资建议。
Trades +21.1% vs the 50-day and +36% vs the 200-day average, 18.6% below the 52-week high and +419% off the 52-week low. Computed from daily closes.
均线状态
- 相对20日均线+10.5%
- 相对50日均线+21.1%
- 相对200日均线+36%
- 52周区间低于52周高点18.6% · 高于52周低点419%
- 连续走势连续1个交易日下跌
- 50日均线交叉股价向上穿越50日均线(21个交易日前)
- 随机指标%K 72.9 · %D 70.8(金叉)
FAQ · from the current data · as of 2026-10-12
Quick answers
IBRX当前的Closelook信号是什么?
Uptrend stack intact — Trades +21.1% vs the 50-day and +36% vs the 200-day average, 18.6% below the 52-week high and +419% off the 52-week low. Computed from daily closes.(截至2026-10-12;信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数,不构成投资建议。)
IBRX目前是否位于50日和200日均线上方?
截至2026-10-12,Immunitybio Inc位于50日均线上方(+21.1%),200日均线上方(+36%);距20日均线+10.5%。
IBRX距52周高点有多远?
截至2026-10-12,低于52周高点18.6%,高于52周低点419%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- KRYS Krystal Biotech Incindustry
- PTGX Protagonist Therapeutics Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- RXRX Recursion Pharmaceuticals Incindustry
- EXEL Exelixis Incindustry
- TWST Twist Bioscience Corpindustry
- TECH Bio-Techne Corpindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- RPRX Royalty Pharma Plcindustry
- BION.SW BB Biotech AGindustry
- INCY Incyte Corporationindustry
- JAZZ Jazz Pharmaceuticals PLCindustry
- NTLA Intellia Therapeutics Incindustry